Revefenacin
| Use attributes for filter ! | |
| Trade name | Yupelri |
|---|---|
| Formula | C35H43N5O4 |
| ChemSpider ID | 9928376 |
| PubChem CID | 11753673 |
| Music groups | Tiotropium bromide |
| Formoterol | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2018727 |
About Revefenacin
Revefenacin is a pharmaceutical drug for the treatment of chronic obstructive pulmonary disease. It was approved for use in the United States in 2018. It was developed by Theravance Biopharma and is marketed by Mylan. Revefenacin is formulated as a solution that is nebulized and inhaled.
Revefenacin Photos
